Diversified (DHC) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.5B
Gross Profit
258.9M
17.31%
Operating Income
-52.6M
-3.52%
Net Income
-370.3M
-24.76%
EPS (Diluted)
-$1.55
Balance Sheet Metrics
Total Assets
5.1B
Total Liabilities
3.2B
Shareholders Equity
2.0B
Debt to Equity
1.62
Cash Flow Metrics
Operating Cash Flow
22.3M
Free Cash Flow
112.2M
Revenue & Profitability Trend
Diversified Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.4B | 1.3B | 1.4B | 1.6B |
| Cost of Goods Sold | 1.2B | 1.2B | 1.1B | 1.1B | 1.2B |
| Gross Profit | 258.9M | 236.2M | 174.5M | 291.4M | 395.7M |
| Operating Expenses | 26.5M | 26.1M | 26.4M | 34.1M | 30.6M |
| Operating Income | -52.6M | -74.1M | -91.2M | -13.8M | 94.9M |
| Pre-tax Income | -371.4M | -272.7M | -21.1M | 181.4M | -133.1M |
| Income Tax | 467.0K | 445.0K | 710.0K | 1.4M | 1.2M |
| Net Income | -370.3M | -293.6M | -15.8M | 179.9M | -134.3M |
| EPS (Diluted) | -$1.55 | -$1.23 | -$0.07 | $0.73 | -$0.59 |
Income Statement Trend
Diversified Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 430.2M | 262.5M | 697.4M | 1.0B | 203.3M |
| Non-Current Assets | 4.7B | 5.2B | 5.3B | 5.6B | 6.3B |
| Total Assets | 5.1B | 5.4B | 6.0B | 6.6B | 6.5B |
| Liabilities | |||||
| Current Liabilities | 38.1M | 29.9M | 734.6M | 838.1M | 51.8M |
| Non-Current Liabilities | 3.1B | 3.1B | 2.6B | 3.1B | 3.8B |
| Total Liabilities | 3.2B | 3.1B | 3.4B | 4.0B | 3.9B |
| Equity | |||||
| Total Shareholders Equity | 2.0B | 2.3B | 2.6B | 2.7B | 2.6B |
Balance Sheet Composition
Diversified Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -370.3M | -293.6M | -15.8M | 179.9M | -134.3M |
| Operating Cash Flow | 22.3M | -20.0M | 223.5M | 376.8M | 92.4M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Investing Cash Flow | -19.5M | 14.5M | 122.9M | 367.0M | 0 |
| Financing Activities | |||||
| Dividends Paid | -9.6M | -9.6M | -9.6M | -9.5M | -42.8M |
| Financing Cash Flow | -22.3M | -949.7M | -776.0M | 746.7M | -1.0B |
| Free Cash Flow | 112.2M | 10.5M | -40.4M | -63.3M | 158.5M |
Cash Flow Trend
Diversified Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-2.40
Forward P/E
-4.00
Price to Book
0.46
Price to Sales
0.59
PEG Ratio
-4.00
Profitability Ratios
Profit Margin
-19.38%
Operating Margin
-1.24%
Return on Equity
-13.96%
Return on Assets
-0.55%
Financial Health
Current Ratio
16.95
Debt to Equity
144.76
Beta
2.43
Per Share Data
EPS (TTM)
-$1.23
Book Value per Share
$8.07
Revenue per Share
$6.31
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| dhc | 887.8M | -2.40 | 0.46 | -13.96% | -19.38% | 144.76 |
| Welltower | 100.9B | 87.65 | 2.96 | 3.48% | 12.65% | 49.20 |
| Ventas | 28.9B | 194.30 | 2.52 | 1.38% | 2.82% | 108.90 |
| LTC Properties | 1.6B | 18.35 | 1.69 | 9.39% | 43.17% | 65.01 |
| Sila Realty Trust | 1.3B | 38.10 | 0.96 | 2.48% | 19.29% | 43.23 |
| Global Medical REIT | 852.7M | 209.00 | 0.95 | 1.43% | 5.75% | 127.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.